Globally, more than 3 million new cases and 10 000 deaths have been reported in the week of 26 December 2022 to 1 January 2023. This represents a reduction in weekly cases and deaths of 22% and 12%, respectively. In the last 28 days (5 December 2022 to 1 January 2023), over 14.5 million cases and ov...er 46 000 new fatalities were reported globally – an increase of 25% and 21%, respectively, compared to the previous 28 days. As of 1 January 2023, over 656 million confirmed cases and over 6.6 million deaths have been reported globally.
In this edition, we include:
The COVID-19 epidemiological update at the global and regional levels.
An update on the circulating SARS-CoV-2 variants of concern (VOCs) and Omicron subvariants under monitoring.
An update on hospitalizations and ICU admissions related to COVID-19.
more
Since 1996, trachoma has been targeted for elimination as a public health problem worldwide. The active trachoma criterion for national elimination as a public health problem is a TF1–9 < 5%, sustained for at least two years in the absence of antibiotic mass drug administration (MDA), in each form...erly endemic EU. Using A, F and E, health ministries and their partners have made considerable progress towards achieving this criterion in formerly endemic EUs worldwide. In 2002, an estimated 1517 million people lived in EUs in which EU-wide implementation of the A, F and E components of SAFE were thought to be needed for the purposes of global elimination of trachoma as a public health problem; by June 2021, that number had fallen to 136.2 million, a 91% reduction. Approximately 85% of the 136.2 million people living in EUs needing A, F and E in June 2021 were in WHO’s African Region.
more
Trachoma is the leading infectious cause of blindness (2). It is characterized by repeated
conjunctival infection with particular strains of Chlamydia trachomatis. This scars the conjunctivae and,
in some cases, leads to trichiasis with or without entropion. The abrasive action of eyelashes can
d...amage the cornea. In 2018, trachoma affected the poorest residents of the poorest communities of 43
countries
more
Esta nueva hoja de ruta traza el camino a seguir para las acciones a nivel de país con el fin de alcanzar un ambicioso conjunto de objet ivos de prevención del VIH para 2025. Estos objetivos surgieron de la Declaración Política sobre el VIH y el sida de 2021, que la Asamblea General de las Nacio...nes Unidas adoptó en junio de 2021 y están respaldados por la Estrategia mundial contra el sida (2021-2026). La Estrategia establece los principios, los enfoques, el área de acción prioritaria y los objetivos programáticos para la respuesta mundial al VIH.
more
Cette nouvelle feuille de route trace la voie à suivre pour les actions à mener au niveau national afin d’atteindre un ensemble ambitieux d’objectifs de prévention du VIH d’ici 2025. Ces objectifs sont issus de la Déclaration politique 2021 sur le VIH et le sida, que l’Assemblée génér...ale des Nations Unies a adoptée en juin 2021 et ils sont étayés par la Stratégie mondiale de lutte contre le sida (2021-2026). La Stratégie définit les principes, les approches, les domaines d’action prioritaires et les objectifs programmatiques de la riposte mondiale au VIH.
more
WHO Fact sheets, questions and answers.
Trachoma is a disease of the eye and the leading infectious cause of blindness worldwide.
Trachoma is one of the 17 WHO-defined Neglected Tropical Diseases
(NTDs) that affect over 1 billion of the world’s poorest and most
marginalized people. It is caused by the bacterium chlamydia trachomatis.
Trichiasis is when the eyelashes turn inward towards the eye and scratch the eye. All the lashes may turn in and rub, or it may be just a few eyelashes. The person with trichiasis usually feels pain, like something is in the eye before the vision is damaged,
blindness will be prevented.
Leishmaniose cutanée : un important problèmede santé
La leishmaniose cutanée est une maladie potentiellement grave et défigurante. Les personnes atteintes de leishmaniose cutanée ont une ou plusieurs lésions durables sur la peau, le plus souvent sans fièvre ni symptômes généraux. L'impac...t de la leishmaniose cutanée sur la propagation de la pauvreté est important, car le traitement est coûteux et donc inabordable ou implique une grande perte d’argent.
Le coût du traitement et de la mise en œuvre de stratégies de prévention nécessite un investissement considérable de ressources financières et humaines. La leishmaniose cutanée est un problème de santé publique majeur dans la Région de l'OMS pour la Méditerranée orientale. Des nouveaux cas apparaissent dans des zones précédemment indemnes de la maladie. Plus de 100 000 nouveaux cas de leishmaniose cutanée sont notifiés chaque année à l'OMS par les pays de la Région, mais les estimations relatives à l'incidence réelle sont de trois à cinq fois plus élevées car de nombreux patients ne consultent jamais un médecin ou un professionnel de santé et les cas ayant reçu un diagnostic de leishmaniose cutanée ne sont pas toujours notifiés aux autorités sanitaires.
more
This publication represents a key step forward in translating Control of the leishmaniases (WHO Technical Report Series, No. 949) into a more practical tool for health personnel directly involved in the case management of cutaneous leishmaniasis. With this manual, countries will have, for the first ...time, standardized diagnosis and treatment protocols, case definitions and indicators to enable them to easily track progress on cutaneous leishmaniasis case management across the Region. It will provide support to professionals in charge of cutaneous leishmaniasis, in order to alleviate the suffering of affected populations from this appalling disfiguring and stigmatizing neglected tropical disease.
more
International commitment to eliminate trachoma as a public health problem worldwide is supported by resolution WHA51.11 of the World Health Assembly .1 Important progress towards this goal has been made by harnessing the mostly informal relationships that exist between partners including Member Stat...es, the World Health Organization (WHO), academic institutions, donors and nongovernmental organizations. Recognizing that work remains to be done and that the 2020 target2 for elimination is rapidly approaching, in February 2015 the WHO Department of Control of Neglected Tropical Diseases convened a group of academic institutions that had for many years helped WHO to implement its mandate on trachoma and to work towards establishing a Network of WHO collaborating centres (WHOCCs) for Trachoma. The report of that meeting has been published.
more
Trachoma disease
Trachoma is a sequela following infection by the bacterium Chlamydia trachomatis (C. trachomatis). The disease is preventable, but still the cause of blindness in 1.9 million people world wide.
Trachoma is a bacterial eye infection found in poor, isolated communities lacking basic hygiene, clean water, and adequate sanitation.
Trachoma is easily spread from person to person through eye-seeking flies, hands, and clothes. Repeated infection over time leads to scarring and inward turning o...f the eyelid, causing the eyelashes to scratch the cornea — a very painful condition called trachomatous trichiasis — which eventually causes blindness if left untreated.
more
Trachoma is a bacterial eye infection, not unlike the common ‘pink-eye’ or conjunctivitis. Repeated reinfection, combined with the body’s immune reaction, often has devastating consequences.
Trachoma starts as an infection of the membrane that covers the outside of the eyeball and lines th...e inner surface of the eyelids (conjunctiva). Repeated infections can over years eventually lead to scarring that causes the margin of the eyelid to turn inwards.
more
Trachoma is a neglected tropical disease. It occurs in some of the poorest populations with limited access to clean water, sanitation, and healthcare, and is the leading cause of blindness in the world. Based on 2020 data, it is estimated that 137 million people are at risk of trachoma in 44 endemic... countries.
more
Yaws forms part of a group of chronic bacterial infections commonly known as the endemic treponematoses. These diseases are caused by spiral bacteria of the genus Treponema, which also includes endemic syphilis (bejel) and pinta. Yaws is the most common of these three infections.
La Confédération internationale des sages-femmes (ICM) a mis au point les Normes internationales pour la réglementation de la pratique de sage-femme (2011) de l'ICM en réponse aux demandes des sages-femmes, des associations de sages-femmes, des
gouvernements, des agences onusiennes et d'autres ...parties prenantes. Ces normes ont pour objectif de promouvoir des mécanismes de réglementation qui protègent le public (les femmes et leurs enfants) en s'assurant que des sages-femmes compétentes et fiables fournissent des niveaux de soins élevés à chaque femme et à chaque bébé. La
réglementation vise à aider les sages-femmes à travailler de manière autonome sur l'ensemble de leur champ d'activité. En relevant le statut des sages-femmes par le biais de la réglementation, le niveau des soins de maternité et la santé des mères et des bébés s'en trouveront renforcés.
more
En la era del cambio digital, democrático, social y político, la comunicación se ha convertido en un medio esencial para expresar ideas y desarrollar iniciativas revolucionarias, capaces de crear comunidades más fuertes, mejor informadas y más comprometidas que nunca. El surgimiento del periodi...smo ético se ha vuelto fundamental para las salas de prensa y es el pilar de las noticias periodísticas que favorecen el desarrollo de la sociedad. Al comenzar estos cambios, la cuestión del género se vuelve inseparable del tema del progreso y del periodismo ético.
more
Trachoma is an eye infection that for thousands of years caused many people to go blind across all continents. As the result of development and targeted interventions, trachoma is now limited to an estimated 57 countries, often affecting the poorest
populations of the world. Today, more than 2 mill...ion people are either blind or suffer from a very painful disability as the result of trachoma.
more
The Practical manual on laboratory strengthening, 2022 update provides practical guidance on implementation of WHO recommendations and best practices for TB laboratory strengthening. It is an updated version of the GLI Practical Guide to Laboratory Strengthening published in 2017 and provides the la...test practical guidance on use of newly recommended diagnostics as well as guidance in key technical areas, including quality assurance and quality management systems, specimen collection and registration, procurement and supply-chain management, diagnostic connectivity, biosafety, data management, human resources, strategic planning, and model algorithms. The key changes are:
inclusion of recent or updated WHO recommendations for tests to diagnose TB and detect drug resistance;
alignment with the latest WHO critical concentrations for phenotypic drug-susceptibility testing (DST) and the new definitions of pre-XDR-TB and XDR-TB;
updated information on building quality-assured TB testing and management capacity using the Stepwise Laboratory Quality Improvement Process Towards Accreditation (SLIPTA) approach (Score-TB package1);
updated information on assessing, analysing and optimising TB diagnostic networks; and
updated information on the use of next-generation sequencing (NGS) to detect mutations associated with drug resistance for surveillance purposes.
The document also provides references to resources and tools relevant for work on laboratory strengthening.
more